DeFi
Injective Launches Staking ETP on Euronext Exchanges
Friday. July 19 at 5:30 AM
1 min. readAsset manager 21Shares has introduced an Injective exchange-traded product (ETP) on Euronext exchanges, expanding the range of crypto investment options. The Injective Staking ETP (AINJ) will mirror Injective's performance and utilize staking rewards for reinvestment. With $128.6 million in assets under management, AINJ is backed by INJ held in cold storage by a custodian. This ETP, available on Euronext Paris and Euronext Amsterdam, is supported by major financial institutions like Interactive Brokers and eToro. By leveraging Injective's proof-of-stake consensus, AINJ can stake INJ for network security and rewards. The ETP landscape in Europe is growing, with offerings like Ethereum staking ETPs and Grayscale's Dynamic Income Fund. Injective, backed by Binance and Mark Cuban, has made significant strides in 2021 and 2022, showcasing its unique features and competitive advantages.